Dystrophic cardiomyopathy: Role of TRPV2 channels in stretch-induced cell damage

Cardiovascular Research

Volumn 106, Issue 1, 2015, Pages 153-162

  Lorin, Charlotte ^a   Vögeli, Isabelle ^a   Niggli, Ernst ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Calcium; Dystrophy; mdx cardiomyocytes; SACs; TRPV2 channels

Indexed keywords

BLOCKING ANTIBODY; CALCIUM ION; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VANILLOID RECEPTOR 2; CALCIUM; CALCIUM CHANNEL; TRPV2 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BIOTINYLATION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL DAMAGE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DYSTROPHIC CARDIOMYOPATHY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; IMMUNOCYTOCHEMISTRY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SARCOLEMMA; TRANSVERSE TUBULAR SYSTEM; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; MECHANICAL STRESS; METABOLISM; OSMOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CARDIOMYOPATHIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, CARDIAC; OSMOSIS; SARCOLEMMA; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TRPV CATION CHANNELS;

EID: 84926629908     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv021     Document Type: Article

References (54)

1. Ferlini A, Sewry C, Melis MA, Mateddu A, Muntoni F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscular Disord 1999;9:339-346
2. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986;323:646-650
3. Lorin C, Gueffier M, Bois P, Faivre JF, Cognard C, Sebille S. Ultrastructural and functional alterations of EC coupling elements in mdx cardiomyocytes: an analysis from membrane surface to depth. Cell Biochem Biophys 2013;66:723-736
4. Ervasti JM, Campbell KP.Arole for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823
5. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. PNAS 1993;90: 3710-3714
6. Vandebrouck C. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 2002;158:1089-1096
7. Iwata Y. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel. J Cell Biol 2003;161:957-967
8. Leijendekker WJ, Passaquin AC, Metzinger L, Rüegg UT. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol 1996; 118:611-616
9. Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 2005;436:1025-1029
10. Allen DG, Whitehead NP. Duchenne muscular dystrophy-what causes the increased membrane permeability in skeletal muscle?. Int J Biochem Cell Biol 2011;43:290-294
11. Sachs F. Stretch-activated ion channels: what are they?. Physiology (Bethesda) 2010;25: 50-56
12. Fanchaouy M, Polakova E, Jung C, Ogrodnik J, Shirokova N, Niggli E. Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium 2009; 46:114-121
13. Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 2006;292:H846-H855
14. Matsumura CY, Taniguti APT, Pertille A, Neto HS, Marques MJ. Stretch-activated calcium channel protein TRPC1 is correlated with the different degrees of the dystrophic phenotype in mdx mice. Am J Physiol Cell Physiol 2011;301:C1344-C1350
15. Jung C, Martins AS, Niggli E, Shirokova N. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+signalling and reactive oxygen species-generating pathways. Cardiovasc Res 2008;77:766-773
16. Ullrich ND, Fanchaouy M, Gusev K, Shirokova N, Niggli E. Hypersensitivity of excitationcontraction coupling in dystrophic cardiomyocytes. Am J Physiol Heart Circ Physiol 2009; 297:H1992-H2003
17. Zanou N, Iwata Y, Schakman O, Lebacq J, Wakabayashi S, Gailly P. Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions. FEBS Lett 2009;583:3600-3604
18. Díaz ME, Graham HK, O'Neill SC, Trafford AW, Eisner DA. The control of sarcoplasmic reticulum Ca content in cardiac muscle. Cell Calcium 2005;38:391-396
19. Ward ML, Williams IA, Chu Y, Cooper PJ, Ju YK, Allen DG. Stretch-activated channels in the heart: contributions to length-dependence and to cardiomyopathy. Prog Biophys Mol Biol 2008;97:232-249
20. Harisseh R, Chatelier A, Magaud C, Deliot N, Constantin B. Involvement of TRPV2 and SOCE in calcium influx disorder in DMD primary human myotubes with a specific contribution of 1-syntrophin and PLC/PKCin SOCE regulation. Am J Physiol Cell Physiol 2013; 304:C881-C894
21. Rubinstein J, Lasko VM, Koch SE, Singh VP, Carreira V, Robbins N, Patel AR, Jiang M, Bidwell P, Kranias EG, Jones WK, Lorenz JN. Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance. Am J Physiol Heart Circ Physiol 2014; 306:H574-H584
22. Katanosaka Y, Iwasaki K, Ujihara Y, Takatsu S, Nishitsuji K, Kanagawa M, Sudo A, Toda T, Katanosaka K, Mohri S, Naruse K. TRPV2 is critical for the maintenance of cardiac structure and function in mice. Nat Commun 2014;5:3932
23. Frank JS, Mottino G, Reid D, Molday RS, Philipson KD. Distribution of the Na+-Ca2+ exchange protein in mammalian cardiac myocytes: an immunofluorescence and immunocolloidal gold-labeling study. J Cell Biol 1992;117:337-345
24. Koch SE, Gao X, Haar L, Jiang M, Lasko VM, Robbins N, Cai W, Brokamp C, Varma P, Tranter M, Liu Y, Ren X, Lorenz JN, Wang H-S, Jones WK, Rubinstein J. Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. J Mol Cell Cardiol 2012;53:134-144
25. Swiderski K, Todorov M, Gehrig SM, Naim T, Chee A, Stapleton DI, Koopman R, Lynch GS. Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice. Fibrogenesis Tissue Repair 2014;7:1
26. Juvin V, Penna A, Chemin J, Lin Y-L, Rassendren F-A. Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate. Molecular Pharmacol 2007;72: 1258-1268
27. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, ImaizumiY. TRPV2 is a component of osmotically sensitive cation channels inmurine aortic myocytes. Circ Res 2003; 93:829-838
28. Ng LC, O'Neill KG, French D, Airey JA, Singer CA, Tian H, Shen XM, Hume JR. TRPC1 and Orai1 interact with STIM1 and mediate capacitative Ca2+ entry caused by acute hypoxia in mouse pulmonary arterial smooth muscle cells. AJP: Cell Physiol 2012;303: C1156-C1172
29. Tian Q, Pahlavan S, Oleinikow K, Jung J, Ruppenthal S, Scholz A, Schumann C, Kraegeloh A, Oberhofer M, Lipp P, Kaestner L. Functional and morphological preservation of adult ventricular myocytes in culture by sub-micromolar cytochalasin D supplement. J Mol Cell Cardiol 2012;52:113-124
30. Ramabadran RS, Chancey A, Vallejo JG, Barger PM, Sivasubramanian N, Mann DL. Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. Tex Heart Inst J 2008;35: 16-21
31. Rando TA. Role of nitric oxide in the pathogenesis of muscular dystrophies: a 'two hit' hypothesis of the cause of muscle necrosis. Microsc Res Tech 2001;55:223-235
32. Zhang Y, Tocchetti CG, Krieg T, Moens AL. Oxidative and nitrosative stress in the maintenance of myocardial function. Free Radic Biol Med 2012;53:1531-1540
33. Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, Davies KE, Radda GK, Clarke K. Decreased myocardial n NOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol 1999;31:1857-1862
34. Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 2011;333:1440-1445
35. Vandebrouck A, Sabourin J, Rivet J, Balghi H, Sebille S, Kitzis A, Raymond G, Cognard C, Bourmeyster N, Constantin B. Regulation of capacitative calcium entries by 1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of 1-syntrophin. FASEB J 2007;21:608-617
36. Kyrychenko S, PolákováE, Kang C, Pocsai K, Ullrich ND, Niggli E, Shirokova N. Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. Cardiovasc Res 2013;97:666-675
37. Sarma S, Li N, van Oort RJ, Reynolds C, Skapura DG, Wehrens XHT. Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. PNAS 2010;107: 13165-13170
38. Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. PNAS 2010;107:1559-1564
39. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 2009;15:325-330
40. Allen DG, Gervasio OL, Yeung EW, Whitehead NP. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 2010;88:83-91
41. Dyachenko V, Husse B, Rueckschloss U, Isenberg G. Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels. Cell Calcium 2009;45: 38-54
42. Millay DP, Goonasekera SA, Sargent MA, Maillet M, Aronow BJ, Molkentin JD. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. PNAS 2009;106:19023-19028
43. Owsianik G, Talavera K, Voets T, Nilius B. Permeation and selectivity of TRP channels. Annu Rev Physiol 2006;68:685-717
44. Kowase T, Nakazato Y, Yoko-O H, Morikawa A, Kojima I. Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. Endocr J 2002;49: 349-355
45. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D.Acapsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999;398:436-441
46. Aoyagi K, Ohara Imaizumi M, Nishiwaki C, Nakamichi Y, Nagamatsu S. Insulin/phosphoinositide 3-kinase pathway accelerates the glucose-induced first-phase insulin secretion through TrpV2 recruitment in pancreatic b-cells. Biochem J 2010;432:375-386
47. Perálvarez-Marín A, Doñate-Macian P, Gaudet R. What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?. FEBS J 2013;280:5471-5487
48. Dogra C, Changotra H, Wergedal JE, Kumar A. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophindeficient skeletal muscle in response to mechanical stretch. J Cell Physiol 2006;208: 575-585
49. Iwata Y, Katanosaka Y, Arai Y, Shigekawa M, Wakabayashi S. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. Hum Mol Gen 2009;18:824-834
50. Iwata Y, Ohtake H, Suzuki O, Matsuda J, KomamuraK, Wakabayashi S. Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy. Cardiovasc Res 2013;99:760-768
51. WuL-J, Sweet T-B, Clapham DE. International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 2010; 62:381-404
52. Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 2009;75:1262-1279
53. Hill G, Cihlar T, Oo C, Ho ES, Prior K, Wiltshire H, Barrett J, Liu B, Ward P. The antiinfluenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metab Dispos 2002;30:13-19
54. Morrison LA. Dystrophinopathies. Handb Clin Neurol 2011;101:11-39